Preeclampsia leads to dysregulation of various signaling pathways in placenta

Journal of Hypertension

Volumn 29, Issue 5, 2011, Pages 928-936

  Kang, Jin Hee ^a   Song, Haengseok ^a   Yoon, Jung Ah ^a   Park, Dong Yoon ^b   Kim, Sung Han ^b   Lee, Kyoung Jin ^a   Farina, Antonio ^c   Cho, Yeon Kyung ^a   Kim, Young Nam ^d   Park, Sang Won ^a   Kim, Gi Jin ^a   Shim, Sung Han ^a   Cha, Dong Hyun ^a  

^a CHA University   (South Korea)

^b Digital Genomics Inc   (South Korea)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Inje University   (South Korea)

Author keywords

gene; hypertension; microarray; placenta; preeclampsia; signaling pathway

Indexed keywords

ACTIN; CELL ADHESION MOLECULE; LEPTIN; PEPTIDASE; PROTEASOME; PROTEIN HTRA SERINE PEPTIDASE 1; PROTEIN SIGLEC6; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; GENOME; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; OXIDATIVE PHOSPHORYLATION; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79954867242     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328344a82c     Document Type: Article

References (37)

1. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99:159-167.
2. Ilekis JV, Reddy UM, Roberts JM. Preeclampsia: a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 2007; 14:508-523. (Pubitemid 351168783)
3. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systemic review. Lancet 2006; 367:1066-1074.
4. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93:1049-1059. (Pubitemid 16004866)
5. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000; 96:45-49. (Pubitemid 30336278)
6. Dekker GA, Sibai BM. The immunology of preeclampsia. Semin Perinatol 1999; 23:24-33. (Pubitemid 29095583)
7. Bilban M, Ghaffari-Tabrizi N, Hintermann E, Bauer S, Molzer S, Zoratti C, et al. Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 2004; 117:1319-1328. (Pubitemid 38559810)
8. Von Dadelszen P, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 2002; 81:642-648. (Pubitemid 34830401)
9. Tsoi SC, Cale JM, Bird IM, Kay HH. cDNA microarray analysis of gene expression profiles in human placenta: up-regulation of the transcript encoding muscle subunit of glycogen phosphorylase in preeclampsia. J Soc Gynecol Investig 2003; 10:496-502. (Pubitemid 37510009)
10. Pang ZJ, Xing FQ. Comparative study on the expression of cytokine: receptor genes in normal and preeclamptic human placentas using DNA microarrays. J Perinat Med 2003; 31:153-162.
11. Reimer T, Koczan D, Gerber B, Richter D, Thiesen HJ, Friese K. Microarray analysis of differentially expressed genes in placental tissue of preeclampsia: up-regulation of obesity-related genes. Mol Hum Reprod 2002; 8:674-680. (Pubitemid 34752929)
12. Sood R, Zehnder JL, Druzin ML, Brown PO. Gene expression patterns in human placenta. Proc Natl Acad Sci USA 2006; 103:5478-5483.
13. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004; 32:D258-D261. (Pubitemid 38081651)
14. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 2006; 34:D354-D357.
15. Hamosh A, Scott AF, Amberger J, Bocchini C, Valle D, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2002; 30:52-55. (Pubitemid 34679502)
16. Subramanian A, Tamayo P, Mootha VK,Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102:15545-15550. (Pubitemid 41528093)
17. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe preeclampsia. Placenta 2007; 28:487-497. (Pubitemid 46593762)
18. Enquobahrie DA, Meller M, Rice K, Psaty BM, Siscovick DS, Williams MA. Differential placental gene expression in preeclampsia. Am J Obstet Gynecol 2008; 199:566.e1-566.e11.
19. Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology 2009; 150:452-462.
20. Sitras V, Paulssen RH, Gronaas H, Leirvik J, Hanssen TA, Vartun A, Acharya G. Differential placental gene expression in severe preeclampsia. Placenta 2009; 30:424-433.
21. Pang ZJ, Xing FQ. Comparative profiling of metabolism-related gene expression in preeclamptic and normal pregnancies. Arch Gynecol Obstet 2004; 269:91-95.
22. Zhou R, Zhu Q, Wang Y, Ren Y, Zhang L, Zhou Y. Genomewide oligonucleotide microarray analysis on placentae of preeclamptic pregnancies. Gynecol Obstet Invest 2006; 62:108-114. (Pubitemid 44200491)
23. Reimer T, Koczan D, Gerber B, Richter D, Thiesen HJ, Friese K. Microarray analysis of differentially expressed genes in placental tissue of preeclampsia: up-regulation of obesity-related genes. Mol Hum Reprod 2002; 8:674-680. (Pubitemid 34752929)
24. Hoegh AM, Borup R, Nielsen FC, Sørensen S, Hviid TV. Gene expression profiling of placentas affected by preeclampsia. J Biomed Biotechnol 2010; 2010:787545.
25. Jarvenpaa J, Vuoristo JT, Savolainen ER, Ukkola O, Vaskivuo T, Ryynanen M. Altered expression of angiogenesis-related placental genes in preeclampsia associated with intrauterine growth restriction. Gynecol Endocrinol 2007; 23:351-355. (Pubitemid 47038257)
26. Ajayi F, Kongoasa N, Gaffey T, Asmann YW, Watson WJ, Baldi A, et al. Elevated expression of serine protease HtrA1 in preeclampsia and its role in trophoblast cell migration and invasion. Am J Obstet Gynecol 2008; 199:557 e1-557 e10.
27. Rajakumar A, Michael HM, Daftary A, Jeyabalan A, Gilmour C, Conrad KP. Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins. Placenta 2008; 29:290-299.
28. Hass R, Sohn C. Increased oxidative stress in preeclamptic placenta is associated with altered proteasome activity and protein patterns. Placenta 2003; 24:979-984. (Pubitemid 37321814)
29. Lee KJ, Shim SH, Kang KM, Kang JH, Park DY, Kim SH, et al. Global gene expression changes induced in the human placenta during labor. Placenta 2010; 31:698-704.
30. Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsiaeclampsia. Am J Obstet Gynecol 2009; 200:481.e1-481.e7.
31. Burton GJ, Jauniaux E, Watson AL. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: theBoyd collection revisited. Am J Obstet Gynecol 1999; 181:718-724. (Pubitemid 29453538)
32. Huppertz B, Peeters LL. Vascular biology in implantation and placentation. Angiogenesis 2005; 8:157-167. (Pubitemid 41712845)
33. Rajakumar A, Brandon HM, Daftary A, Ness R, Conrad KP. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta 2004; 25:763-769. (Pubitemid 39276941)
34. Chen L, Endler A, Shibasaki F. Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors. Exp Mol Med 2009; 41:849-857.
35. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, et al. Hypoxia inducible factor-alpha binding and ubiquitylation by the Von Hippel-Lindau tumor suppressor protein. J Biol Chem 2000; 275:25733-25741.
36. KaelinWGJr. The Von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem Biophys Res Commun 2005; 338:627-638.
37. Han J, Li L, Hu J, Yu L, Zheng Y, Guo J, et al. Epidermal growth factor stimulates human trophoblast cell migration through Rho A and Rho C activation. Endocrinology 2010; 151:1732-1742.